CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. Credit: Nemes Laszlo via Shutterstock. The US Food and ...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

The acquisition will provide Torrent with access to a fast-growing Indian franchise and new therapeutic areas such as ophthalmology. Credit: Sai Thaw Kyar/Shutterstock. Torrent Pharmaceuticals, ...

Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.